Pyridostigmine-induced complete atrioventricular block in a patient with Musk antibody-negative myasthenia gravis a case report
This report has highlighted the importance of accurate diagnosis of MG and its autoimmune subtypes, and if treatment is required with pyridostigmine, the importance of follow-up and electrocardiographic monitoring to ensure the rapid diagnosis and management of cardiac conduction abnormalities, even if they are MuSK antibody-negative.
Authors
- Saeed Abrotan (ORCID: https://orcid.org/0000-0003-3991-1365)
- Mohammad Taghi Hedayati Godarzi
- Novin Nikbakhsh (ORCID: https://orcid.org/0000-0002-6803-7358)
- Mohamad Rashid (ORCID: https://orcid.org/0000-0001-6388-5764)
- Marjan Fallah
- Mehdi Seifi
Institutions
- Babol University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1186/s12872-025-04681-0
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39